Deltanoid Pharmaceuticals, Inc. today announced the appointment of former Genzyme/Sanofi renal head, Douglas Jermasek as its new Chief Executive Officer. Co-founder Hector F DeLuca, PhD, MD, DSC will continue as Chairman of the Board of Directors and assume the responsibilities of President and Chief Operating Officer. Co-founder Margaret Clagett-Dame, PhD will continue in her role as Executive Vice President. Read the full WisBusiness story here.
- The Journal Times: 100state is moving to a new downtown location
- WisBusiness: SHINE Medical Technologies is moving from Monona to Janesville, where it’s building a medical radioisotope production facility.
- PRWeb: Catalyze Raises $6.5 Million in Series B Financing to Meet the Growing Need of Trusted Connectivity within Enterprise Healthcare